Bryson W. Katona, MD, PhD
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Director, Gastrointestinal Cancer Genetics Program, Hospital of the University of Pennsylvania
Director, Gastrointestinal Cancer Risk Evaluation Program, Hospital of the University of Pennsylvania
Member, Abramson Cancer Center - Cancer Control Program
Department: Medicine
Graduate Group Affiliations
Contact information
751 Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
South Pavilion
Philadelphia, PA 19104
3400 Civic Center Boulevard
South Pavilion
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Publications
Education:
MS (Chemistry)
University of Pennsylvania, 2002.
BA (Chemistry)
University of Pennsylvania, 2002.
PhD (Biochemistry)
Washington University in St. Louis School of Medicine, 2009.
MD
Washington University in St. Louis School of Medicine, 2009.
Permanent linkMS (Chemistry)
University of Pennsylvania, 2002.
BA (Chemistry)
University of Pennsylvania, 2002.
PhD (Biochemistry)
Washington University in St. Louis School of Medicine, 2009.
MD
Washington University in St. Louis School of Medicine, 2009.
Description of Clinical Expertise
Hereditary gastrointestinal cancer and polyposis syndromes. Gastrointestinal cancer risk evaluation.Description of Research Expertise
Hereditary gastrointestinal cancer and polyposis syndromes. Cellular signaling and epigenetic mechanisms of tumorigenesis in colon cancer and gastroenteropancreatic neuroendocrine tumors.Selected Publications
Kagami LA, Du YK, Fernandes CJ, Le AN, Good M, Duvall MM, Baldino SE, Powers J, Zelley K, States LJ, Mathew MC, Katona BW, MacFarland SP, Maxwell KN.: Rates of intervention and cancer detection on initial versus subsequent whole body MRI screening in Li-Fraumeni Syndrome. Cancer Prev Res (Phila) Jul 2023.Katona BW, Klute K, Brand RE, Everett JN, Farrell JJ, Hawthorne K, Kaul V, Kupfer SS, Paiella S, Simeone DM, Sussman DA, Zogopoulos G, Lucas AL, Kastrinos F; PRECEDE Consortium.: Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Cancer Prev Res (Phila) 16: 343-352, Jun 2023.
Mraz KA, Hodan R, Rodgers-Fouche L, Arora S, Balaguer F, Guillem JG, Jeter JM, Kanth P, Li D, Liska D, Melson J, Perez K, Ricker C, Shirts BH, Vilar E, Katona BW, Dominguez-Valentin M.: Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey. Front Oncol 13: 1141810, May 2023.
Williams S, Ebrahimzadeh JE, Clay D, Constantino G, Heiman J, Wangensteen KJ, Valverde K, Mahmud N, Katona BW.: Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic. Hered Cancer Clin Pract 21: 6, May 2023.
Seppälä TT, Burkhart RA, Katona BW.: Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review. BJS Open 7: zrad023, May 2023.
Farha N, Kumar S, Katona BW, Hüneburg R, Lynch PM, Gupta S, Burke CA.: The Approach to Performance of Quality Upper Endoscopy in Lynch Syndrome (QUELS): An International Expert Statement. J Clin Gastroenterol 57: 31-38, Jan 2023.
Latham A., Liu Y.L., Constantino G., Borio M., Poulin C., McCoy S., Dudzik C., Heiman J., Kemel Y., Ukaegbu C., Ranganathan M., Parenteau M., Kane S., Green D., Long J., Syngal S., Markowitz A.J., Stadler Z.K., Yurgelun M., Katona B.W.: Neoplasia Detection Via Colonoscopic Surveillance Among Young Patients with MSH6 and PMS2-Associated Lynch Syndrome. Poster presentation at the ASCO Annual Meeting, Chicago, IL 2023.
Katona B.W.: What is Lynch syndrome, the genetic condition related to colon cancer? – Five Questions. Interviewee, Philadelphia Inquirer 2023.
Klute K., Lucas A.L., Brand R., Everett J., Farrell J.J., Hawthorne K., Kaul V., Kupfer S.S., Paiella S., Simeone D.M., Sussman D.A., Zogopoulos G., Kastrinos F., Katona B.W., and the PRECEDE Consortium: Racial, ethnic and sex-based disparities among high-risk individuals undergoing pancreatic cancer surveillance - Abstract. Poster presentation at the GI ASCO Annual Meeting 2023.
Niccum B.A., Clay D., Heiman J., Buckley K., Dungan M., Daniel M., Ruiz J., Coughlin S., Leung G., Ahmad N.A., Ginsberg G.G., Kochman M.L., Katona B.W.: Low prevalence of H. pylori and gastric intestinal metaplasia in BRCA1/2 carriers undergoing EUS. Poster presentation at Digestive Disease Week, Chicago, IL 2023.